Aquestive Therapeutics is a specialty pharmacy company that is highly focused on providing treatment options for persons unable to properly swallow medicine.
In this video, Daniel Barber is Chief Operating Officer at Aquestive describes the three medications they have in development. The first is Sympazan (clobazam) for treating Lennox-Gastaut syndrome. The second is Exservan (riluzole) for treating amyotrophic lateral sclerosis (ALS) and the third is Libervant (diazepam) to manage breakthrough seizures.
Aquestive’s drug delivery system employs PharmFilm that allows medications to be applied to a dissolvable film so that patients can place under their tongue. For patients that have difficulty swallowing (such as those with ALS, seizures, etc), this is an ideal method to administer medications.
For more information, visit https://aquestive.com.
